Showing 11 - 20 of 284
We introduce a novel approach to estimating latent oil risk factors and establish their significance in pricing non-oil securities. Our model, which features four factors with simple economic interpretations, is estimated using both derivative prices and oil-related equity returns. The fit is...
Persistent link: https://www.econbiz.de/10013091009
This study develops and estimates a stochastic volatility model of commodity prices that nests many of the previous models in the literature. The model is an affine three-factor model with one state variable driving the volatility and is maximal among all such models that are also identifiable....
Persistent link: https://www.econbiz.de/10012972663
I extract three oil risk factors using oil futures prices and returns of oil related firms. The first factor accounts for news that uniformly affects expected oil prices at all horizons, the second factor accounts for news that affects near term expected oil prices, and the third factor accounts...
Persistent link: https://www.econbiz.de/10012980016
Inclusionary housing policies enacted by municipal governments rely on a combination of legal mandates and economic incentives to encourage residential real estate developers to include affordable units in otherwise market-rate projects. These regulations provide a means of stimulating the...
Persistent link: https://www.econbiz.de/10013056028
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10012466796
The pharmaceutical industry's core business is the innovation, development and marketing of new drugs. Pharmacogenetic (PG) testing and technology has the potential to increase a drug's value in many ways. A critical issue for the industry is whether products in development should be teamed with...
Persistent link: https://www.econbiz.de/10005243212
This paper models how the evolving field of pharmacogenomics (PG), which is the science of using genomic markers to predict drug response, may impact drug development times, attrition rates, costs, and the future returns to research and development (R&D). While there still remains an abundance...
Persistent link: https://www.econbiz.de/10005087441
Persistent link: https://www.econbiz.de/10008348714
Persistent link: https://www.econbiz.de/10010028098
This paper explores stock return predictability by exploiting the cross-section of oil futures prices. Motivated by the principal component analysis, we find the curvature factor of the oil futures curve predicts monthly stock returns: a 1% per month increase in the curvature factor predicts...
Persistent link: https://www.econbiz.de/10012967736